Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01988740Unknown

Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin

Showing all 1 trials

Research Network

Active Sponsors

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital1

Top Investigators

Related Conditions

  • First Trimester Pregnancy1
  • Absence Of Fetal Pole On Ultrasonographic Examination1

Activity Timeline